SCM
KYNB

Sterling Capital Management’s Kyntra Bio KYNB Stock Holding History

Sterling Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-508
Closed -$387K – 935
2015
Q4 		$387K Buy
+508
New +$337K ﹤0.01% 820

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sterling Capital Management's KYNB Position: Q1 2016 in Review

Sterling Capital Management sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 508 shares — an estimated $387K sold.

Sterling Capital Management first reported a position in KYNB in Q4 2015 and held it in 1 quarter. The position peaked at $387K in Q4 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • Sterling Capital Management reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
  • Sterling Capital Management sold 508 Kyntra Bio shares in Q1 2016, an estimated $387K.
  • Sterling Capital Management first reported a position in Kyntra Bio in Q4 2015 and held it in 1 quarter.
  • Sterling Capital Management's Kyntra Bio position peaked at $387K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on Sterling Capital Management's 13F filing for Q1 2016, filed 17 May 2016.